Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Gene Therapy 2.0: Leveraging Transgene Cassette Engineering Ben Josey, PhD, Corning Life Sciences, and Gabriela Denning, PhD, Expression Therapeutics LLC Novel gene therapies are entering the clinic and generating clinical data readouts at an unprecedented rate. As with any new therapy, the key readouts... 3 months ago | 65 mins Viral Safety by Design for Cell and Gene Therapy Products Mark Plavsic, Chief Technology Officer at Lysogene & Archie Lovatt, Life Sciences Biosafety Scientific Director at SGS Together with product efficacy, product safety is an essential characteristic of any medicinal product including cell and gene therapy (C>) biologic... 3 years ago | 67 mins Viral Safety by Design for Cell and Gene Therapy Products Mark Plavsic, Chief Technology Officer at Lysogene & Archie Lovatt, Life Sciences Biosafety Scientific Director at SGS Together with product efficacy, product safety is an essential characteristic of any medicinal product including cell and gene therapy (C>) biologic... 4 years ago | 68 mins Upstream Viral Risk Mitigation Strategy for High Titer Biologics Manufacturing Aaron Mack, Engineer at Biogen & Dave Kolwyck, Director at Biogen and David Gemmell Senior Process Engineer at Merck Presented by Aaron Mack, Engineer at Biogen This talk will focus on the risk based approach that Biogen used for determining which raw materials to i... 3 years ago | 83 mins Application of Next Generation Sequencing (NGS) Based Methods... Jurgen Mulberg Associate Director at Bristol Myers Squibb and Joanna Zmurko, NGS specialist at PathoQuest Full Title: Application of Next Generation Sequencing (NGS) Based Methods for Detection of Viral Contaminants in Biomanufacturing Contamination of a ... 1 year ago | 90 mins Viral Safety by Design for Cell and Gene Therapy Products Mark Plavsic, Chief Technology Officer at Lysogene & Dr. Magali Roche, Sales Manager, PathoQuest, Biologics Genomic Service Presented by Mark Plavsic, Chief Technology Officer at Lysogene Together with product efficacy, product safety is an essential characteristic of any ... 2 years ago | 75 mins Best Practices of Downstream Protein Purification and Product Concentration Krishnamurthy Venkatesan at Biocon Biologics, Sofie Östemar and Henrik Ihre and at Cytiva and Nigel Jackson, Pall Corporation Downstream protein purification and product concentration is known to be the most challenging part of the process development. It is also known that t... 6 months ago | 166 mins Scalable AAV Manufacturing: Addressing Challenges Across the Workflow Chao Yan Liu, Gino Stolfa, Monica Commerford Thermo Fisher Scientific product experts discuss upstream and downstream solutions across the entire workflow. In this webinar, you'll learn about sc... 2 years ago | 85 mins Best Practices of Downstream Protein Purification and Product Concentration Krishnamurthy Venkatesan, Downstream MSAT Lead, Senior Director at Biocon Biologics. Downstream protein purification and product concentration is known to be the most challenging part of the process development. It is also known that t... September 12, 2023 10:00am Clinical and biochemical data-driven drug re-purposing for anti-infective drugs Andrey Khudoshin Drug repurposing has been shown to be advantageous for treating rare and common diseases. A data-driven drug repurposing approach may not only acceler... 3 years ago | 79 mins
